<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR207.html">Part 207
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 207.20  Who must register and submit a drug list.
                            </h3>
                            <p class="depth1"><em>(a)(1)</em> of the act must be listed whether or not the output of such  establishments or any particular drug so listed enters interstate  commerce. No owner or operator may register an establishment if any part  of the establishment is registered by any other owner or operator.</p><p class="depth1"><em>(b)</em> Owners or operators of establishments not otherwise required to  register under section 510 of the act that distribute under their own  label or trade name a drug manufactured or processed by a registered  establishment may elect to submit listing information directly to FDA  and to obtain a Labeler Code. A distributor who submits drug listing  information shall include the registration number of the drug  establishment that manufactured, prepared, propagated, compounded, or  processed each drug listed. All distributors who submit drug listing  information to FDA assume full responsibility for compliance with all of  the requirements of this part. Each such distributor at the time of  submitting or updating drug listing information as required under Sec.  207.30 shall certify to the registered establishment that the submission  has been made by providing a signed copy of Form FDA-2656 (Registration  of Drug Establishment) to the registered establishment that manufactures  or processes the drug. Each such distributor shall submit the original  of Form FDA-2656 showing this certification to FDA, and shall accompany  the certification with a list showing the National Drug Code number that  the distributor has assigned to each drug product. If a distributor does  not elect to submit drug listing information directly to FDA and to  obtain a Labeler Code, the registered establishment shall submit the  drug listing information. Distributors or registered establishments  shall use Form FDA-2658 (Registered Establishments' Report of Private  Label Distributors) to submit drug listing information or to request a  Labeler Code, or both.</p><p class="depth1"><em>(c)</em> Before beginning manufacture or processing of a drug subject to  one of the following applications, an owner or operator of an  establishment is required to register before the agency approves or  grants it: A new drug application, an abbreviated new drug application,  a new animal drug application, an abbreviated new animal drug  application, a medicated feed mill license application, a biologics  license application, or a request for addition to the index.</p><p class="depth1"><em>(d)</em> No registration fee is required.</p><p class="depth1"><em>(e)</em> Registration and listing do not constitute an admission, or  agreement, or determination that a product is a drug as defined in  section 201(g) of the act.</p><p class="depth1"><em>(f)</em> Owners and operators of establishments or persons engaged in the  recovery, screening, testing, processing, storage, or distribution of  human cells, tissues, and cellular and tissue-based products, as defined  in Sec. 1271.3(d) of this chapter, that are regulated under section 351  of the Public Health Service Act and/or the Federal Food, Drug, and  Cosmetic Act must register and list those human cells, tissues, and  cellular and tissue-based products with the Center for Biologics  Evaluation and Research on Form FDA 3356 following the procedures set  out in subpart B of part 1271 of this chapter, instead of the   procedures for registration and listing contained in this part, except  that the additional listing information requirements in Sec. 207.31  remain applicable.  [45 FR 38043, June 6, 1980, as amended at 45 FR 32293, May 16, 1980; 52  FR 2682, Jan. 26, 1987; 55 FR 11576, Mar. 29, 1990; 64 FR 400, Jan. 5,  1999; 64 FR 56448, Oct. 20, 1999; 64 FR 63203, Nov. 19, 1999; 66 FR  5466, Jan. 19, 2001; 66 FR 59157, Nov. 27, 2001; 66 FR 5447, Jan. 19,  2001; 72 FR 69120, Dec. 6, 2007]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
